In accordance with § 3 sec. 2b GCP Ordinance, the investigator must conduct an informed consent discussion informing the patient comprehensively about the content of the trial, its benefit, risks and treatment alternatives before they may be enrolled in a clinical trial. Furthermore, the patient will receive the patient information which is written in a…